.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Merck
Boehringer Ingelheim
Accenture
Novartis
US Department of Justice
McKesson
Teva
Cipla
Cerilliant

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206129

« Back to Dashboard

NDA 206129 describes TETRABENAZINE, which is a drug marketed by Actavis Labs Fl Inc, Apicore Us, Hetero Labs Ltd V, and Sun Pharma Global, and is included in four NDAs. It is available from five suppliers. Additional details are available on the TETRABENAZINE profile page.

The generic ingredient in TETRABENAZINE is tetrabenazine. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the tetrabenazine profile page.

Summary for 206129

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 206129

Medical Subject Heading (MeSH) Categories for 206129

Suppliers and Packaging for NDA: 206129

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TETRABENAZINE tetrabenazine TABLET;ORAL 206129 ANDA Sun Pharma Global FZE 47335-179 47335-179-23 112 TABLET in 1 BOTTLE (47335-179-23)
TETRABENAZINE tetrabenazine TABLET;ORAL 206129 ANDA Sun Pharma Global FZE 47335-277 47335-277-23 112 TABLET in 1 BOTTLE (47335-277-23)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG
Approval Date:Aug 17, 2015TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Aug 17, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Baxter
Express Scripts
Deloitte
Healthtrust
US Army
QuintilesIMS
Novartis
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot